J Urol Oncol > Volume 22(1); 2024 > Article
Editorial Office, Korean Urological Oncology Society: Declaration of Conflict of Interest for Editorial Board Members’ Articles
The journal’s policy in handling editors’ or in-house staff’s manuscript was posted on January 1, 2023 at the “instructions for authors (https://www.e-juo.org/authors/authors.php)” and “principles of transparency and best practice (https://www.e-juo.org/about/best_practice.php)” sections as follows:
“All manuscripts from editors, employees, or members of the editorial board are processed the same as other unsolicited manuscripts. During the review process, submitters will not engage in the decision process. Editors will not handle their own manuscripts, although they are commissioned ones. We neither guarantee the acceptance without review nor very short peer review times for unsolicited manuscripts. Commissioned manuscripts also were reviewed before publication.”
Therefore, the conflict of interest declaration of the following 7 articles are added as follows:
1. Ito K, Kimura T. Complex Epidemiology of Prostate Cancer in Asian Countries. Journal of Urologic Oncology 2023; 21(1):5-13. https://doi.org/10.22465/juo.234600140007.
Conflict of Interest
Takahiro Kimura has been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
2. Kim JE, Lee K, Kim IY. Current Update on Prostate Cancer Immunotherapy. Journal of Urologic Oncology 2023;21(1):14-22. https://doi.org/10.22465/juo.234600100005.
Conflict of Interest
Isaac Y. Kim has been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
3. Akamatsu S, Mizuno K, Sumiyoshi T, Goto T, Kobayashi T. The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies. Journal of Urologic Oncology 2023;21(1):23-31. https://doi.org/10.22465/juo.234600060003.
Conflict of Interest
Shusuke Akamatsu has been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
4. Ko YH, Kim SW, Kim H, Bae YJ. The Use of 5-Alpha Reductase Inhibitors Improves the Detection of Prostate Cancer by Increasing Opportunities for Repeated Prostate-Specific Antigen Testing: A Decade-Long (2007-2016) Nationwide Observational Study in Korea. Journal of Urologic Oncology 2023;21(1):53-58. https://doi.org/10.22465/juo.234600020001.
Conflict of Interest
Young Hwii Ko has been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
5. Choi J, Song C, Suh J, Kang M, Choi CI, Yuk HD, et al. Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey. Journal of Urologic Oncology 2023;21(1):59-69. https://doi.org/10.22465/juo.234600120006.
Conflict of Interest
Young Hwii Ko and Cheol Kwak have been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
6. Kim JH, Ko YH, Kim JW, Kang SH, Jung SI, Park JS, et al. The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy. Journal of Urologic Oncology 2023;21(1):79-87. https://doi.org/10.22465/juo.224400340017.
Conflict of Interest
Young Hwii Ko, Jong Wook Kim, and Jong Jin Oh have been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
7. Ku JY, Gu HM, Yu SH, Hwang EC, Han MA, Jung JH, et al. Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery? Journal of Urologic Oncology 2023;21(2):140-147. https://doi.org/10.22465/juo.234600180009.
Conflict of Interest
Cheol Kwak has been an editorial board member of Science Editing since 2023 but has no role in the decision to publish this article. Except for that, no potential conflict of interest relevant to this article was reported. The opinions provided in this manuscript reflect the authors’ personal views and do not represent that of their affiliated organizations.
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 174 View
  • 2 Download
Related articles


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI